Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
|Slideshows|December 5, 2018
Top 5 articles on maternal mortality in 2018
As 2018 comes to a close, we're taking a look back at some of the most popular articles this year. These were the top articles from our Maternal Mortality Special Series.
Advertisement
As 2018 comes to a close, we're taking a look back at some of the most popular articles this year. These were the top articles from our Maternal Mortality Special Series.
Advertisement
Related to this article
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
JoAnn V. Pinkerton, MD, offers primary care counseling on elinzanetant's side effects and the early onset and continued relief of hot flashes.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
TMS 2026: HSDD biopsychosocial approach, night sweats red flags, misread WHI data
2
Neurokinin receptor antagonists improve menopausal sleep disturbance
3
How misread WHI data reshaped menopause care and training
4
Brain fog at menopause: Separating normal change from dementia
5